Related Experiment Video
Updated: Aug 22, 2025
09:12
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
16.1K
Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation
Joel Gruchot1, Ferdinand Lein1, Isabel Lewen1
1Department of Neurology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, D-40225 Dusseldorf, Germany.
International Journal of Molecular Sciences
|November 11, 2022
Summary
Siponimod modulates microglia, key cells in multiple sclerosis (MS) central nervous system inflammation. This sphingosine 1-phosphate receptor modulator may offer new therapeutic avenues for managing neuroinflammation in MS.
Area of Science:
- Neuroimmunology
- Pharmacology
Background:
- Microglia play dual roles in the central nervous system (CNS), contributing to both neurorepair and neuroinflammation in multiple sclerosis (MS).
- Siponimod, a sphingosine 1-phosphate receptor (S1PR) modulator, is approved for treating relapsing-remitting and active secondary progressive MS.
- Siponimod crosses the blood-brain barrier and targets S1PR1 and S1PR5 on CNS cells, including microglia.
Purpose of the Study:
- To investigate the effect of siponimod on microglial activation in the context of neuroinflammation.
- To determine if siponimod can modulate the pro-inflammatory response of microglia.
Main Methods:
- Lipopolysaccharide (LPS) was used to induce pro-inflammatory activation in microglia.
- The impact of siponimod on this LPS-induced microglial reaction was assessed.
Main Results:
- Siponimod demonstrated the ability to modulate the pro-inflammatory activation of microglia induced by LPS.
- This suggests a potential mechanism for siponimod's therapeutic effects in MS by influencing microglial behavior.
Conclusions:
- Siponimod can alter the inflammatory state of microglia, which are critical in MS pathogenesis.
- These findings support siponimod's role in managing CNS inflammation and potentially promoting neuroprotection in multiple sclerosis.
